Prévisions du marché de la radio-oncologie en Amérique du Nord jusqu\'en 2031 - Analyse régionale - par types (radiothérapie externe et radiothérapie interne) et applications (cancer du sein, cancer de la prostate, cancer du poumon, cancer de la tête et du cou, cancer du col de l\'utérus et autres)
La prévalence croissante du cancer alimente le marché nord-américain de la radio-oncologie
Le cancer est l\'un des problèmes de santé courants qui ont un impact significatif sur la société mondiale. Selon l\'Organisation mondiale de la santé (OMS), le cancer est la principale cause de décès dans le monde, représentant 9,7 millions de décès et 20 millions de nouveaux cas de cancer en 2023 et il devrait atteindre environ 35 millions de nouveaux cas de cancer d\'ici 2050. Selon le rapport 2024 de l\'OMS, le cancer du poumon est le cancer le plus courant et la principale cause de décès dans le monde, suivi du cancer colorectal, du cancer du foie, du cancer du sein et du cancer de l\'estomac, représentant respectivement 18,7 %, 9,3 %, 7,8 %, 6,9 % et 6,8 % du total des décès.
La prévalence et l\'incidence croissantes du cancer créent une demande d\'options de traitement efficaces. La radiothérapie est l\'une des options de traitement en évolution pour les patients atteints de cancer avec un résultat efficace qui utilise les doses élevées de rayonnement telles que les rayons X, les rayons gamma et autres pour tuer les cellules cancéreuses. La radiothérapie est utilisée dans les premiers stades du cancer et divers types de radiothérapie externe sont utilisés pour le traitement de différents cancers. Par exemple, la curiethérapie est utilisée pour le traitement du cancer du sein, du cancer du col de l\'utérus, du cancer des yeux, du cancer de la prostate et du cancer de la tête et du cou. De même, la radiothérapie systémique est également connue sous le nom d\'iode radioactif et est utilisée pour le traitement du cancer de la thyroïde. La radiothérapie peut être utilisée à tout moment du traitement et peut être associée à d\'autres traitements tels que la chirurgie, la chimiothérapie, l\'immunothérapie et autres. Par conséquent, la prévalence croissante du cancer et l\'évolution de la radiothérapie en oncologie devraient stimuler la croissance du marché de la radio-oncologie.
Aperçu du marché nord-américain de la radio-oncologie
La radiothérapie est largement disponible pour tous les patients atteints de cancer aux États-Unis, et le besoin de radio-oncologues est en constante augmentation. Le nombre de ces professionnels augmente également en permanence en raison de l\'infrastructure de santé développée. Néanmoins, l\'American Society of Clinical Oncology estime qu\'environ les deux tiers des patients atteints de cancer dans le monde recevront une radiothérapie dans le cadre de leur traitement. En 2023, plus d\'un million de patients atteints de cancer aux États-Unis devraient subir une radiothérapie chaque année. Le gouvernement et les autorités sanitaires prennent plusieurs initiatives pour encourager l\'adoption de la radiothérapie. En juin 2020, l\'American Society for Radiation Oncology (ASTRO) a introduit de nouvelles directives cliniques concernant la radiothérapie pour le cancer du col de l\'utérus non métastatique. Les nouvelles directives se concentrent sur la mise en œuvre précise des étapes et des processus pour mener une radiothérapie.
Chiffre d\'affaires et prévisions du marché de la radio-oncologie en Amérique du Nord jusqu\'en 2031 (en millions de dollars américains)
Segmentation du marché de la radio-oncologie en Amérique du Nord
Le marché nord-américain de la radio-oncologie est classé en types, applications et pays.
Sur la base des types, le marché nord-américain de la radio-oncologie est divisé en radiothérapie externe et radiothérapie interne. Le segment de la radiothérapie externe détenait une part de marché plus importante en 2023.
En termes d\'application, le marché nord-américain de la radio-oncologie est classé en cancer du sein, cancer de la prostate, cancer du poumon, cancer de la tête et du cou, cancer du col de l\'utérus et autres. Le segment du cancer du sein détenait la plus grande part de marché en 2023.
Par pays, le marché nord-américain de la radio-oncologie est segmenté en États-Unis, Canada et Mexique. Les États-Unis ont dominé la part de marché nord-américaine de la radio-oncologie en 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare et Curium sont quelques-unes des principales entreprises opérant sur le marché nord-américain de la radio-oncologie.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. North America Radiation Oncology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. North America Radiation Oncology Market - Key Market Dynamics
5.1 Market Drivers:
5.1.1 Increasing Prevalence of Cancer
5.1.2 Initiatives to Support Developments in Radiation Oncology
5.2 Market Restraints
5.2.1 High Cost of Radiotherapy Equipment
5.3 Market Opportunities
5.3.1 Strategic Initiatives in Radiation Oncology
5.4 Future Trends
5.4.1 Technological Advancement in Radiation Oncology
5.5 Impact of Drivers and Restraints:
6. Radiation Oncology Market - North America Market Analysis
6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
7. North America Radiation Oncology Market Analysis - by Types
7.1 External Beam Radiation Therapy
7.1.1 Overview
7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
7.2.1 Overview
7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Radiation Oncology Market Analysis - by Application
8.1 Breast Cancer
8.1.1 Overview
8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
8.2.1 Overview
8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
8.3.1 Overview
8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
8.4.1 Overview
8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
8.5.1 Overview
8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Radiation Oncology Market - Country Analysis
9.1 North America Radiation Oncology Market Overview
9.1.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
9.1.1.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.1.1 United States: Radiation Oncology Market Breakdown, by Types
9.1.1.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.1.4 United States: Radiation Oncology Market Breakdown, by Application
9.1.1.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.2.1 Canada: Radiation Oncology Market Breakdown, by Types
9.1.1.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.2.4 Canada: Radiation Oncology Market Breakdown, by Application
9.1.1.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
9.1.1.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
10. Radiation Oncology Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Varian Medical Systems Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Elekta AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Accuray Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Becton Dickinson and Co
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 NTP RADIOISOTOPES
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Mallinckrodt Plc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Provision Healthcare
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Curium
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. North America Radiation Oncology Market Segmentation
Table 2. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Recent Organic Growth Strategies in Radiation Oncology Market
Table 15. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 16. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. North America Radiation Oncology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Radiation Oncology Market - Key Market Dynamics
Figure 4. Statistics at Glance, Global, 2022
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 7. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 8. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 11. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. North America Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 18. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 19. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Perspective Therapeutics Inc.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Provision Healthcare.
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.